Company intelligence / Profile preview

MileCell Biotechnology

Shanghai, Shanghai Municipality, Chinamilecell-bio.com ↗
Ownership
Private
Development stage
Other
01

Overview

MileCell Biotechnology provides high-quality primary human and animal cell products and related CRO services to pharmaceutical companies and research labs. Their offerings support drug discovery through commercialization stages by supplying immune/human blood-derived primary cells, hepatic modeling solutions including hepatocytes/NPCs/subcellular fractions for ADME/toxicity testing, as well as specialty media/reagents such as their Kryogene™ cryopreservation solution. They do not develop their own therapeutic drugs but are an important enabler in the life sciences R&D ecosystem.

Therapeutic areas
Immunology
Modalities
Primary human and animal cells (PBMCs, T cells, B cells, NK cells, Monocytes, CD34+)Hepatocytes and non-parenchymal liver cellsSubcellular fractions for ADME researchMedia/reagents/kits for cell culture and cryopreservation
Industry
Non-Drug Biotech
02

Partnerships

No specific major partnerships disclosed; works with pharmaceutical companies broadly as clients.

Beyond the preview

Go deeper on MileCell Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MileCell Biotechnology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call